PVLA Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. (PVLA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 99% planned / 1% discretionary
Largest single sale: $982.0K.
Where they traded
Last open-market purchase: March 30, 2026 , by JENKINS GEORGE M .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Goin Kathleen 3 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $152.24 | $654.9K | 2,643 −61.9% of holding | |
| JENKINS GEORGE M 3 fills | Director | Sell 10b5-1 | 1,777 | $150.14 | $266.8K | 160,939 −1.1% of holding | |
| JENKINS GEORGE M 3 fills | Director | Sell 10b5-1 | 13,352 | $151.96 | $2.0M | 169,613 −7.3% of holding | |
| JENKINS GEORGE M 3 fills | Director | Sell 10b5-1 | 12,371 | $151.28 | $1.9M | 181,096 −6.4% of holding | |
| KIRITSY CHRISTOPHER P | Director | Sell | 313 | $157.00 | $49.1K | 250 −55.6% of holding | |
| Goin Kathleen 5 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $152.21 | $654.8K | 2,802 −60.6% of holding | |
| Goin Kathleen 4 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $149.28 | $642.2K | 3,780 −53.2% of holding | |
| Goin Kathleen 3 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $110.73 | $476.4K | 1,912 −69.2% of holding | |
| Goin Kathleen 3 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $110.56 | $475.6K | 939 −82.1% of holding | |
| Goin Kathleen 5 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $127.24 | $547.4K | 2,800 −60.6% of holding | |
| JENKINS GEORGE M | Director | Buy | 445 | $112.30 | $50.0K | 187,616 | |
| Goin Kathleen 3 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $117.99 | $507.6K | 2,034 −67.9% of holding | |
| JENKINS GEORGE M | Director | Buy | 4,000 | $125.00 | $500.0K | 187,171 | |
| HERON ELAINE J | Director | Buy | 2,400 | $125.00 | $300.0K | 47,812 | |
| Goin Kathleen 2 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $79.40 | $341.6K | 1,276 −77.1% of holding | |
| Goin Kathleen 2 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $97.63 | $420.0K | 3,749 −53.4% of holding | |
| Goin Kathleen | Chief Operating Officer | Sell 10b5-1 | 4,302 | $96.47 | $415.0K | None left | |
| Goin Kathleen 2 fills | Chief Operating Officer | Sell 10b5-1 | 4,302 | $86.23 | $371.0K | 2,802 −60.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.